Description: Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Home Page: www.sutrobio.com
STRO Technical Analysis
111 Oyster Point Boulevard
South San Francisco,
CA
94080
United States
Phone:
650 881 6500
Officers
| Name | Title |
|---|---|
| Mr. William J. Newell J.D. | CEO & Director |
| Mr. Edward C. Albini | CFO & Sec. |
| Dr. Trevor J. Hallam | Pres of Research & Chief Scientific Officer |
| Ms. Jane Chung R.Ph. | Chief Commercial Officer |
| Dr. James R. Swartz Ph.D., Sc.D. | Founder |
| Dr. Shabbir T. Anik | Chief Technical Operations Officer |
| Ms. Annie J. Chang M.B.A. | VP of Investor Relations |
| Mr. David Pauling J.D., M.A. | Gen. Counsel |
| Ms. Linda A. Fitzpatrick | Chief People & Communications Officer |
| Dr. Nicki Vasquez Ph.D. | Chief Portfolio Strategy & Alliance Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.8764 |
| Price-to-Sales TTM: | 6.0527 |
| IPO Date: | 2018-09-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 259 |